期刊文献+
共找到41篇文章
< 1 2 3 >
每页显示 20 50 100
Muscular atrophy and weakness in the lower extremities in Behçet’s disease: A case report and review of literature
1
作者 Koh-Woon Kim Jae-Heung Cho 《World Journal of Clinical Cases》 SCIE 2021年第20期5647-5654,共8页
BACKGROUND In Behçet’s disease(BD),very few cases of muscular involvement have been reported previously.The natural history and therapeutic protocol for muscular involvement in BD are obscure due to the low inci... BACKGROUND In Behçet’s disease(BD),very few cases of muscular involvement have been reported previously.The natural history and therapeutic protocol for muscular involvement in BD are obscure due to the low incidence of peripheral neuropathy or myopathy in BD.The purpose of our study was to report a rare case of BD with chronic,focal forms of neuromyopathy and review the relevant literature.CASE SUMMARY We herein report the case of a 54-year-old man who presented with progressive muscular atrophy and weakness of both thighs 2 years after the presentation of the cardinal symptoms of BD.The past medical history,electrophysiological study,neurological examination,blood tests,magnetic resonance imaging study,and histological exam were performed for the differential diagnosis.Relevant literature on muscular involvement in BD was reviewed.Neurological examination revealed that muscular involvement was predominantly localized in the proximal parts of the lower extremities.Heterogeneous enhancement of several thigh muscles was observed on magnetic resonance imaging,which corresponded with the clinical manifestations.Histological study of one of the enhanced muscles showed denervation atrophy of the muscle with superimposed myopathic changes,while electrophysiological studies only suggested denervation.CONCLUSION To our knowledge,this is the first case of neurogenic muscular atrophy with a specific set of clinical,radiological,electrophysiological,and histological findings reported in BD. 展开更多
关键词 behçet’s disease Muscular atrophy Muscular weakness NEUROPATHY MYOPATHY Case report
暂未订购
Successful splenic artery embolization in a patient with Behçet’s syndrome-associated splenic rupture:A case report
2
作者 Guang-Zhao Zhu Dong-Hua Ji 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第4期1184-1188,共5页
BACKGROUND Splenic rupture associated with Behçet’s syndrome(BS)is extremely rare,and there is no consensus on its management.In this case report,a patient with BSassociated splenic rupture was successfully trea... BACKGROUND Splenic rupture associated with Behçet’s syndrome(BS)is extremely rare,and there is no consensus on its management.In this case report,a patient with BSassociated splenic rupture was successfully treated with splenic artery embolization(SAE)and had a good prognosis after the intervention.CASE SUMMARY The patient was admitted for pain in the left upper abdominal quadrant.He was diagnosed with splenic rupture.Multiple oral and genital aphthous ulcers were observed,and acne scars were found on his back.He had a 2-year history of BS diagnosis,with symptoms of oral and genital ulcers.At that time,he was treated with oral corticosteroids for 1 month,but the symptoms did not alleviate.He underwent SAE to treat the rupture.On the first day after SAE,the patient reported a complete resolution of abdominal pain and was discharged 5 d later.Three months after the intervention,a computed tomography examination showed that the splenic hematoma had formed a stable cystic effusion,suggesting a good prognosis.CONCLUSION SAE might be a good choice for BS-associated splenic rupture based on good surgical practice and material selection. 展开更多
关键词 Splenic artery embolization behçet’s syndrome Splenic rupture Case report
暂未订购
Behçet病急性黄斑神经视网膜病变1例
3
作者 蔡志鹏 张红 +1 位作者 陶永健 严京 《中华眼底病杂志》 北大核心 2025年第12期965-968,共4页
患者男,29岁。因右眼眼前固定黑影遮挡1年余,左眼突发视力下降4 h,于2024年10月23日至中国中医科学院眼科医院就诊。既往Behçet病史7年余,间断出现口腔、外阴溃疡,皮肤针刺试验阳性,曾于外院予以口服糖皮质激素治疗(具体剂量不详)... 患者男,29岁。因右眼眼前固定黑影遮挡1年余,左眼突发视力下降4 h,于2024年10月23日至中国中医科学院眼科医院就诊。既往Behçet病史7年余,间断出现口腔、外阴溃疡,皮肤针刺试验阳性,曾于外院予以口服糖皮质激素治疗(具体剂量不详),但未规律服药。2周前患者无明显诱因相继出现复发性口腔溃疡和双侧膝关节痛,尚未接受任何治疗。否认前驱流感样症状及眼球转动痛,否认外伤、感染性疾病及药物过敏史。眼科检查:右眼、左眼最佳矫正视力(BCVA)分别为1.0、0.3。 展开更多
关键词 behçet 急性黄斑神经视网膜病变 病例报告
原文传递
核因子-κappa B信号通路在Behçet病中的研究现状与进展
4
作者 郑传珍 张晓敏 《中华眼底病杂志》 CAS CSCD 北大核心 2023年第10期862-867,共6页
Behçet病(BD)是一种多系统血管炎,病情交替反复发作缓解为主要特征,涉及生殖器、口腔、眼、皮肤和关节等器官。核因子(NF)-κB信号通路在BD发展中有重要作用。蛋白学研究发现,BD患者中NF-κB通路活化标志为血浆CD40配体高表达,其... Behçet病(BD)是一种多系统血管炎,病情交替反复发作缓解为主要特征,涉及生殖器、口腔、眼、皮肤和关节等器官。核因子(NF)-κB信号通路在BD发展中有重要作用。蛋白学研究发现,BD患者中NF-κB通路活化标志为血浆CD40配体高表达,其通过刺激中性粒细胞释放活性氧和细胞外陷阱来促进炎症。细胞学研究发现,BD患者巨噬细胞通过NF-κB通路极化为经典活化巨噬细胞型,加剧炎症。活化NF-κB与T细胞抗凋亡蛋白表达相关,延长炎症状态。微生物学研究发现,BD患者肠道菌群减少导致肠道屏障受损,NF-κB通路参与中性粒细胞和辅助性T细胞(Th)1/Th17细胞功能调控,加剧炎症。基因学研究发现,BD患者免疫调节基因多态性,通过NF-κB通路促发炎症。BD患者NF-κB相关基因突变增加风险,A20内源性抑制剂突变导致NF-κB异常活跃,维持炎症。动物实验和体外细胞实验证实,NF-κB抑制剂减轻炎症,靶向NF-κB信号通路上游炎症因子药物在BD患者疗效良好。NF-κB信号通路在BD发展中发挥关键作用,研发NF-κB抑制剂可能成为治疗BD的新途径。未来仍需进一步研究NF-κB在BD发病机制中的详细作用及其在临床治疗中的应用前景。 展开更多
关键词 behçet 核因子-ΚB信号通路 肠道菌群 基因多态性 抑制剂 综述
原文传递
Behçet Disease with Generalized Polymorphous Cutaneous Lesions:A Case Report
5
作者 Li-Wei Wang Ling-Ling Luo +2 位作者 Wei Zhang Xue-Si Zeng Pan-Gen Cui 《International Journal of Dermatology and Venereology》 2022年第3期175-177,共3页
Introduction:Behçet disease is a chronic multisystem vasculitis disease,however generalized polymorphous cutaneous lesions are uncommon.Here,we reported a case of Behçet disease with multiple parts of the bo... Introduction:Behçet disease is a chronic multisystem vasculitis disease,however generalized polymorphous cutaneous lesions are uncommon.Here,we reported a case of Behçet disease with multiple parts of the body and complex lesions,which may lead to misjudging in clinical diagnosis.Case report:A 69-year-old man presented with a seven-year history of recurrent generalized polymorphous mucocutaneous lesions(erythematous papules,nodules,ulcers,and necrosis)over his entire body,and the lesions had been painful for the past three years.Based on the past medical history,clinical presentation,histological examination excluded other diseases,and the 2014-amended International Criteria for Behget disease,the patient had a score of 6 points and was diagnosed as Behçet disease.Discussion:The common clinical feature in patients with Behçet syndrome is the presence of recurrent and usually painful mucocutaneous ulcers.Other clinical manifestations of this disorder are more variable among different patients.A diagnosis of generalized polymorphous cutaneous lesions should remain on the list of differential diagnosis of Behçet disease after excluding other diseases.Conclusion:The mucocutaneous lesions of Behçet disease are often preceded by other manifestations,and timely diagnosis may benefit early treatment and prognosis. 展开更多
关键词 behçet disease cutaneous lesions generalized lesions poloymorphous
原文传递
Right Ventricular Thrombus and Tricuspid Valve Dysfunction in a Patient with Behçet’s Disease
6
作者 Federica Valente Christian Motet +1 位作者 Stefan Rusu Frederic Vandergheynst 《Case Reports in Clinical Medicine》 2020年第10期319-328,共10页
<strong>Background:</strong> Beh<span style="white-space:nowrap;">&ccedil;</span>et’s disease (BD) is a multisystemic, chronic inflammatory disorder with a broad range of manifes... <strong>Background:</strong> Beh<span style="white-space:nowrap;">&ccedil;</span>et’s disease (BD) is a multisystemic, chronic inflammatory disorder with a broad range of manifestations including within the cardiovascular system. Cardiac involvement like intracardiac thrombus (ICT) and valvular involvement in BD are rarely seen entities and often associated with poor prognosis. <strong>Case Presentation: </strong>We present the case of a young patient with vascular-Beh<span style="white-space:nowrap;">&ccedil;</span>et diagnosed by the presence of intracardiac thrombus in the right ventricle, unresponsive to medical treatment. Even though the intracardiac lesion was successfully treated by surgical excision, he presented a severe tricuspid dysfunction some years later due to the extension of fibrosis with no surgical therapeutic option. <strong>Conclusion:</strong> Intracardiac thrombosis is a rare but early manifestation of Beh<span style="white-space:nowrap;">&ccedil;</span>et’s disease, which is difficult to diagnose and has a poor prognosis. 展开更多
关键词 behçet’s Disease Cardiac Involvement Intracardiac Thrombosis Tricuspid Valve Regurgitation Endomyocardial Fibrosis
暂未订购
Epidemiology and Clinical Profile of Behcet’s Disease in a Sub-Saharan Country: About Five Observations
7
作者 Thierno Amadou Wann Mamadou Lamine Yaya Bah +5 位作者 Mamadou Saliou Baldé Abdoul Karim Baldé Toumin Camara Ibrahima Kalil Shiaman Barro Amadou Kaké Djibril Sylla 《Open Journal of Internal Medicine》 2023年第2期120-125,共6页
Behçet’s disease (BD) is a multi-systemic vasculitis characterized by a triad made up of oral aphthosis, genital aphthosis and uveitis which may or may not be associated with visceral involvement. Other times de... Behçet’s disease (BD) is a multi-systemic vasculitis characterized by a triad made up of oral aphthosis, genital aphthosis and uveitis which may or may not be associated with visceral involvement. Other times described in the ancient silk road, BD is increasingly found in countries south of the Sahara with the mixing of populations. Our objective was to describe the epidemiology and clinical characteristics of BD in an African country. Methodology: This was a five-year retrospective study in the internal medicine department of Donka National Hospital. We used international criteria finding BD. Urinary dipstick was use for finding kidney disease. Result: During the period, five cases of Behçet’s disease were collected. The average age was 35 years old. The male sex was more represented with 3 out of 5 cases. The most common clinical manifestation was oral aphthosis in all patients (100%), followed by genital aphthosis in 4 cases (80%). The other clinical manifestations observed were uveitis in 3 cases (60%), joint manifestations such as arthralgia in 3 cases (60%) and neurological manifestations such as chronic headache in one case (20%). HLA-B51 was found in two cases. The pattergic test done in two patients came back positive (100%). The patients received colchicine and oral corticosteroid therapy. Two patients were lost to sight. We deplored a death probably in a neuro-Behçet table before the rebellious headaches. Conclusion: Behçet’s disease is a multi-systemic vasculitis that must be evoked and managed quickly in a tropical environment, especially since the prognosis, vital and functional prognosis can be engaged. 展开更多
关键词 Profile EPIDEMIOLOGICAL Clinical behçet Sub-Saharan
暂未订购
白术内酯Ⅰ对白塞病小鼠脾脏Th17/Treg平衡的影响
8
作者 吴紫陆 丁虹 +1 位作者 蔡纪堂 宋会玲 《西部中医药》 2026年第4期1-4,共4页
目的:研究白术内酯Ⅰ对白塞病小鼠脾脏辅助性T细胞17(T helper cells 17,Th17)/调节性T细胞(regulatory T cell,Treg)平衡的影响。方法:将60只BALB/c小鼠随机分为空白组、模型组和实验组,每组20只,参考文献方法进行造模。空白组与模型... 目的:研究白术内酯Ⅰ对白塞病小鼠脾脏辅助性T细胞17(T helper cells 17,Th17)/调节性T细胞(regulatory T cell,Treg)平衡的影响。方法:将60只BALB/c小鼠随机分为空白组、模型组和实验组,每组20只,参考文献方法进行造模。空白组与模型组小鼠给予等体积0.9%的生理盐水,实验组给予白术内酯Ⅰ干预。采用流式细胞术检测小鼠脾脏中Th17和Treg细胞数量;采用酶联免疫吸附(enzyme-linked immunosorbent assay,ELISA)法检测各组小鼠脾脏中Th17细胞因子白细胞介素6(interleukin-6,IL-6)、IL-17水平及Treg细胞因子IL-4和IL-10的表达水平;采用蛋白免疫印迹法检测小鼠脾脏中Th17关键调控因子维甲酸相关孤儿受体γt(retinoic acid-related orphan receptor gamma t,RORγt)及Treg关键调控因子叉头/翼状螺旋转录因子3(forkhead box p3,Foxp3)的表达水平。结果:与空白组相比,模型组小鼠Th17、IL-6、IL-17、RORγt表达水平及Th17/Treg比值均升高(P<0.05);IL-10、Treg、Foxp3表达水平均降低(P<0.05)。与模型组相比,实验组小鼠Th17、IL-6、IL-17、RORγt表达水平及Th17/Treg比值均降低(P<0.05);IL-10、Treg及Foxp3表达水平均升高(P<0.05)。结论:白术内酯Ⅰ可能通过调节Th17/Treg免疫失衡,改善原肌球蛋白诱导的白塞病小鼠的免疫功能。 展开更多
关键词 白塞病 白术内酯Ⅰ 白细胞介素17 辅助性T细胞17 调节性T细胞 动物实验
暂未订购
Molecular and therapeutic effects of mesenchymal stem cell-derived exosomes on autoimmune diseases
9
作者 Fatma Sengul Bag Omer Faruk Bag 《World Journal of Stem Cells》 2025年第7期37-54,共18页
Autoimmune diseases are complex clinical conditions that present significant therapeutic challenges due to their intricate immunological mechanisms.Conventional treatment strategies,such as immunosuppressive drugs and... Autoimmune diseases are complex clinical conditions that present significant therapeutic challenges due to their intricate immunological mechanisms.Conventional treatment strategies,such as immunosuppressive drugs and anti-inflammatory therapies,often demonstrate limited efficacy and are associated with considerable side effects.Recently,mesenchymal stem cells(MSCs)have attracted growing interest as a promising therapeutic approach,owing to their immunomodulatory properties and ability to promote tissue repair.However,the direct application of MSCs faces several limitations,including the risk of immunogenicity and difficulties in large-scale production.In this context MSC-derived exosomes(MSC-Exos),nano-sized extracellular vesicles secreted by MSCs,have emerged as a compelling alternative to cell-based therapies.Enriched with proteins,lipids,and nucleic acids,these exosomes exhibit potent anti-inflammatory and immunomodulatory effects.Their primary mechanisms of action include enhancing the population of regulatory T cells,modulating macrophage polarization,and suppressing proinflammatory cytokines such as interleukin-6 and tumor necrosis factor-α.The therapeutic potential of MSC-Exos extends beyond individual conditions,encompassing a wide range of autoimmune diseases.For instance in Behçet’s disease,they have been shown to regulate vasculitis and inflammatory processes by inhibiting proinflammatory cytokines and promoting endothelial cell regeneration.Moreover,MSC-Exos have demonstrated promising immunomodulatory effects in other autoimmune diseases,including systemic lupus erythematosus,rheumatoid arthritis,and multiple sclerosis.Through mechanisms such as inflammation suppression,vascular repair,and the restoration of immune homeostasis,MSC-Exos represent a versatile and innovative approach to autoimmune disease therapy.This review explored the molecular and therapeutic effects of MSCs and MSC-Exos in autoimmune diseases,with particular emphasis on their clinical potential in Behçet’s disease,systemic lupus erythematosus,rheumatoid arthritis,and multiple sclerosis. 展开更多
关键词 Mesenchymal stem cells EXOSOMES Autoimmune diseases IMMUNOMODULATION behçet’s disease Systemic lupus erythematosus Rheumatoid arthritis Multiple sclerosis
暂未订购
儿童白塞综合征45例临床特征分析
10
作者 魏晨曦 智树凤 +4 位作者 蒋丽君 赵雪 苏庆晓 齐兴杰 戎赞华 《中国当代儿科杂志》 北大核心 2025年第10期1253-1258,共6页
目的 探讨儿童白塞综合征(Beh?et syndrome, BS)的临床特征,为儿童BS的诊治提供参考。方法 回顾性分析2014年12月—2024年12月于河北医科大学第二医院儿科住院且符合BS诊断标准患儿的临床资料。结果 45例BS患儿中,男性26例(58%),临床表... 目的 探讨儿童白塞综合征(Beh?et syndrome, BS)的临床特征,为儿童BS的诊治提供参考。方法 回顾性分析2014年12月—2024年12月于河北医科大学第二医院儿科住院且符合BS诊断标准患儿的临床资料。结果 45例BS患儿中,男性26例(58%),临床表现以口腔溃疡最常见(43例,96%),其余包括生殖器溃疡23例(51%),消化系统受累18例(40%)等。生殖器溃疡女性多见,眼部病变男性多见(P<0.05)。针刺试验阳性10例(22%),人类白细胞抗原-B51阳性13例(29%)。粪便钙卫蛋白(fecal calprotectin, FC)升高16例(36%),FC升高患儿消化系统受累比例高于FC正常患儿(P<0.05)。符合1990年白塞病国际研究组诊断标准17例(38%),2014年白塞病国际评分标准33例(73%),2015年儿童白塞病诊断标准13例(29%)。结论 儿童BS临床表现异质性强,人类白细胞抗原-B51与其发病相关。 展开更多
关键词 白塞综合征 临床特征 粪便钙卫蛋白 人类白细胞抗原-B51 儿童
暂未订购
基于“厥阴阳郁”思路辨治白塞病 被引量:2
11
作者 姚晓玲 蒋总 +1 位作者 杨豫正 马武开 《中华中医药杂志》 北大核心 2025年第5期2412-2415,共4页
白塞病(BD)发病率逐年上升,因发病机制不明,目前西医尚缺乏根治BD的特效药。诸多临床实践研究表明,中医药在改善BD临床症状、提高生活质量和预防复发方面疗效显著。文章从“厥阴病”角度阐释BD发病机理与证治要点,分析了BD从经络厥阴、... 白塞病(BD)发病率逐年上升,因发病机制不明,目前西医尚缺乏根治BD的特效药。诸多临床实践研究表明,中医药在改善BD临床症状、提高生活质量和预防复发方面疗效显著。文章从“厥阴病”角度阐释BD发病机理与证治要点,分析了BD从经络厥阴、八纲厥阴角度立论,强调BD发病机理为厥阴寒邪郁遏馁阳,阴阳相搏,阴阳失和,寒热错杂,从“厥阴阳郁”进行辨证治疗,介绍厥阴病主方乌梅丸的溯源、临证加减并附医案予以分析,为BD的治疗寻求新的思路和方案。 展开更多
关键词 白塞病 厥阴阳郁 乌梅丸 狐惑病 思路
原文传递
骨髓增生异常综合征合并贝赫切特综合征的机制及治疗研究进展
12
作者 付慧 余建 《浙江大学学报(医学版)》 北大核心 2025年第1期131-139,共9页
骨髓增生异常综合征是克隆性造血组织肿瘤,表现为慢性血细胞减少症伴细胞形态发育异常,易进展为骨髓衰竭或急性髓系白血病。贝赫切特综合征是一类特殊的系统性血管炎,主要表现为复发性口腔溃疡、皮肤损害、眼部炎症等。近年来,骨髓增生... 骨髓增生异常综合征是克隆性造血组织肿瘤,表现为慢性血细胞减少症伴细胞形态发育异常,易进展为骨髓衰竭或急性髓系白血病。贝赫切特综合征是一类特殊的系统性血管炎,主要表现为复发性口腔溃疡、皮肤损害、眼部炎症等。近年来,骨髓增生异常综合征合并贝赫切特综合征的病例报道增多,提示两者之间存在潜在的病理联系。免疫细胞的异常激活、细胞因子的异常分泌以及细胞遗传学改变等可能在骨髓增生异常综合征合并贝赫切特综合征的发病机制中起重要作用。目前,骨髓增生异常综合征合并贝赫切特综合征的治疗策略主要基于个体化原则,包括免疫抑制治疗、细胞毒性药物治疗、靶向治疗及造血干细胞移植等。然而,由于病例报道较少及机制研究不足,治疗方案的选择仍需探讨。本文综述了骨髓增生异常综合征与贝赫切特综合征的关联性及其机制,总结了相关治疗进展,以期为该类患者的临床管理和相关机制的进一步研究提供参考。 展开更多
关键词 骨髓增生异常综合征 贝赫切特综合征 遗传 免疫 治疗 综述
暂未订购
MiR-665、STAT3和IL-17在白塞葡萄膜炎发病中的作用
13
作者 魏碧霞 宋艳 丁琳 《新疆医学》 2025年第3期280-284,共5页
目的检测白塞葡萄膜炎(Behçet’s uveitis,BU)与正常对照组标本中miR-665、STAT3、p-STAT3、IL-17的表达差异,探讨分子指标在疾病中发挥的生物学功能作用。方法选取2022年01月至2022年09月期间在新疆维吾尔自治区人民医院眼科就诊... 目的检测白塞葡萄膜炎(Behçet’s uveitis,BU)与正常对照组标本中miR-665、STAT3、p-STAT3、IL-17的表达差异,探讨分子指标在疾病中发挥的生物学功能作用。方法选取2022年01月至2022年09月期间在新疆维吾尔自治区人民医院眼科就诊的BU患者作为实验组(15例),选取年龄和性别均分别匹配的健康人作为对照组(15例),分别抽取外周静脉血4-6ml,检测miR-665、STAT3、p-STAT3、IL-17的表达水平。结果实验组miR-665、p-STAT3、IL-17的表达高于对照组,差异有统计学意义(P<0.05),STAT3在实验组与对照组中的表达无统计学差异(P>0.05)。结论BU患者miR-665、p-STAT3、IL-17表达异常,其三者可能参与了BU的发生和发展过程。 展开更多
关键词 微小RNA665 信号传导及转录激活蛋3 白介素-17 白塞葡萄膜炎
暂未订购
生物制剂治疗白塞氏病葡萄膜炎的研究进展
14
作者 牟庆帅 刘滨 +1 位作者 毕泗松 解孝锋 《中国中医眼科杂志》 2025年第2期190-194,200,共6页
白塞氏病是一种累及多系统的慢性自身免疫性疾病,葡萄膜炎是其眼部并发症,可导致严重的视力损害。近年来,随着对白塞氏病葡萄膜炎(BU)发病机制的深入研究,抗肿瘤坏死因子-α(TNF-α)制剂在其治疗中取得了重要进展。本文对TNF-α抑制剂... 白塞氏病是一种累及多系统的慢性自身免疫性疾病,葡萄膜炎是其眼部并发症,可导致严重的视力损害。近年来,随着对白塞氏病葡萄膜炎(BU)发病机制的深入研究,抗肿瘤坏死因子-α(TNF-α)制剂在其治疗中取得了重要进展。本文对TNF-α抑制剂、干扰素-α(IFN-α)等生物制剂在BU治疗中的临床疗效、作用机制及安全性的研究进展进行综述,发现生物制剂能够显著降低BU患者的复发率,改善视力,且具有良好的耐受性。虽然生物制剂在BU治疗中的应用已经取得了一定的临床证据,但仍需进一步优化治疗方案以及预防感染。本研究可为BU的临床诊治提供参考。 展开更多
关键词 白塞氏病 葡萄膜炎 生物制剂 TNF-Α
暂未订购
中西医结合治疗白塞病葡萄膜炎1例并文献复习
15
作者 贾元玲 项敏泓 《中国医药科学》 2025年第6期172-175,180,共5页
白塞病是一种慢性全身性血管炎症性疾病,其病因和发病机制尚不完全清楚,临床上以葡萄膜炎、复发性口腔溃疡、阴部溃疡和皮肤损害为主要特征,其眼部表现主要为复发性非肉芽肿性葡萄膜炎和闭塞性视网膜血管炎,好发于中青年,易复发,治疗困... 白塞病是一种慢性全身性血管炎症性疾病,其病因和发病机制尚不完全清楚,临床上以葡萄膜炎、复发性口腔溃疡、阴部溃疡和皮肤损害为主要特征,其眼部表现主要为复发性非肉芽肿性葡萄膜炎和闭塞性视网膜血管炎,好发于中青年,易复发,治疗困难,临床预后较差、致盲率较高。现报道白塞病葡萄膜炎患者1例,根据患者情况进行中西医结合治疗,并结合文献进行总结分析,探讨该疾病的治疗方案,从而为此类患者的综合治疗提供更多的新思路。 展开更多
关键词 白塞病 葡萄膜炎 狐惑病 中西医结合治疗
暂未订购
中性粒细胞的双重作用:白塞综合征机制与靶向治疗载体应用进展
16
作者 曾富郡 唐柔 +3 位作者 吕成贞 张宇佳 吴东 郑稳生 《药学学报》 北大核心 2025年第7期2167-2177,共11页
白塞综合征(Behçet's syndrome,BS)是一种罕见的慢性免疫/炎症性疾病,特征为复发性口腔阿弗他溃疡及其他多种全身性表现,可导致多种严重并发症甚至死亡。BS的确切发病机制尚未完全阐明,近年来,多项研究发现中性粒细胞功能亢进... 白塞综合征(Behçet's syndrome,BS)是一种罕见的慢性免疫/炎症性疾病,特征为复发性口腔阿弗他溃疡及其他多种全身性表现,可导致多种严重并发症甚至死亡。BS的确切发病机制尚未完全阐明,近年来,多项研究发现中性粒细胞功能亢进和趋化性增强是BS发病机制的重要组成部分。本文从中性粒细胞过度活化、释放中性粒细胞胞外陷阱和产生过量活性氧3个方面对其参与BS发病机制的最新研究进展进行综述,旨在为BS的发病机制和临床诊治提供理论依据。基于中性粒细胞在BS疾病过程中扮演的关键角色,本文进一步综述了中性粒细胞靶向药物递送系统的研究进展,以期为靶向调控中性粒细胞治疗BS提供参考。 展开更多
关键词 中性粒细胞 白塞综合征 发病机制 药物递送系统 靶向递送
原文传递
白塞病性葡萄膜炎并发视网膜新生血管的临床及影像学特征分析
17
作者 陈雪琳 张雄泽 《眼科学报》 2025年第2期103-112,共10页
目的:探讨白塞病性葡萄膜炎(Behçet's uveitis, BU)并发视盘新生血管(neovascularization of the optic disc,NVD)和(或)视盘以外视网膜新生血管(retinal neovascularization elsewhere, NVE)的临床及影像特征。方法:回顾性分... 目的:探讨白塞病性葡萄膜炎(Behçet's uveitis, BU)并发视盘新生血管(neovascularization of the optic disc,NVD)和(或)视盘以外视网膜新生血管(retinal neovascularization elsewhere, NVE)的临床及影像特征。方法:回顾性分析2022年1月—2024年9月就诊的BU并发NVD和(或)NVE患者的临床资料和眼底影像学检查结果,包括眼底彩照、荧光素眼底血管造影(fluorescein fundus angiography, FFA)、光学相干断层成像(optical coherence tomography, OCT)和光学相干断层血管成像(OCT angiography, OCTA)。并分析NVD和(或)NVE面积与患眼的改良的眼后段炎症评分以及视网膜血管渗漏评分的相关性。结果:共纳入27例患者(30只眼),年龄为(27.70±12.58)岁,男女比例约为1:1。3例(11%)患者双眼并发NVD和(或)NVE;25只眼(83%)存在NVD:17只眼(57%)仅有NVD;8只眼(27%)存在NVD和NVE。仅2只眼(7%)存在视网膜无灌注区,7只眼(23%)同时发生玻璃体积血。FFA眼后段炎症评分为(20.93±4.37)分。FFA血管渗漏评分为(7.57±1.25)分。NVD和(或)NVE面积与眼后段炎症评分(rs=0.403,P=0.027)及视网膜血管渗漏评分(rs=0.518,P=0.003)均呈正相关。FFA与OCTA在检测NVD和NVE上表现完全一致(κ=1.0)。结论:BU并发NVD和(或)NVE并不罕见,以NVD为主,绝大多数与视网膜无灌注不相关,可能由BU炎症诱发。 展开更多
关键词 白塞病性葡萄膜炎 视网膜新生血管 视盘新生血管 多模式影像 炎症
暂未订购
生物制剂在白塞综合征中的治疗进展 被引量:3
18
作者 鲍华芳 管剑龙 《复旦学报(医学版)》 CAS CSCD 北大核心 2022年第4期588-595,共8页
白塞综合征(Behçet’s syndrome,BS)机制不明,多系统损害及内脏受累患者预后差。α干扰素和单克隆抗肿瘤坏死因子α抗体可以改善内脏受累BS患者的预后,但仍有一部分患者为难治性BS。其他生物制剂治疗BS已取得一定的临床疗效。阿那... 白塞综合征(Behçet’s syndrome,BS)机制不明,多系统损害及内脏受累患者预后差。α干扰素和单克隆抗肿瘤坏死因子α抗体可以改善内脏受累BS患者的预后,但仍有一部分患者为难治性BS。其他生物制剂治疗BS已取得一定的临床疗效。阿那白滞素和康纳单抗可改善BS葡萄膜炎和皮肤黏膜症状;司库奇尤单抗可能对皮肤黏膜和关节表型BS患者有效;托珠单抗对BS葡萄膜炎、中枢神经受累和血管受累患者疗效较好,但对皮肤黏膜、关节和肠道受累患者疗效较差;优特克单抗似乎对BS难治性皮肤黏膜症状和葡萄膜炎有效。上述药物治疗BS的有效性和安全性均有待进一步临床研究。 展开更多
关键词 白塞综合征(BS) 生物制剂 白细胞介素(IL)
暂未订购
加强炎性动脉瘤的认识与鉴别 被引量:1
19
作者 蔡青 邵壮 +1 位作者 全振涛 高洁 《第二军医大学学报》 CAS CSCD 北大核心 2021年第9期961-966,共6页
炎性动脉瘤是指一类与动脉炎症疾病相关的动脉瘤,多由风湿免疫性疾病所致。炎性动脉瘤发生率低,症状隐匿,治疗方法与动脉粥样硬化及创伤等导致的动脉瘤迥异,故病因诊断和鉴别诊断尤为重要。临床遇到年轻的动脉瘤患者伴发热、贫血、乏力... 炎性动脉瘤是指一类与动脉炎症疾病相关的动脉瘤,多由风湿免疫性疾病所致。炎性动脉瘤发生率低,症状隐匿,治疗方法与动脉粥样硬化及创伤等导致的动脉瘤迥异,故病因诊断和鉴别诊断尤为重要。临床遇到年轻的动脉瘤患者伴发热、贫血、乏力、体重下降等非特异性表现及临床炎性指标如红细胞沉降率、CRP等增高时,应高度警惕炎性动脉瘤可能。本文系统介绍了风湿免疫性疾病并发炎性动脉瘤的概念和发病情况,以备临床医师查阅、参考。 展开更多
关键词 动脉瘤 炎性动脉瘤 系统性血管炎 TAKAYASU动脉炎 贝赫切特综合征
原文传递
上一页 1 2 3 下一页 到第
使用帮助 返回顶部